Instrument Inactif

Cours Ocera Therapeutics Inc

Actions

Durée

Période

Style

Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®	20/10/17
Ocera Therapeutics Selected to Present an Oral Presentation and Three Posters on OCR-002 at the AASLD Liver Meeting® 2017	23/08/17
Ocera Therapeutics Reports Second Quarter 2017 Financial Results	01/08/17
Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis	01/06/17
Ocera Therapeutics to Host KOL Conference Call on Hepatic Encephalopathy and Other Complications of Liver Disease on Friday, June 2	26/05/17

Secteur

	Varia. 1 janv.	Capi.
CSL LIMITED	-2,86 %	87,31 Md
SAMSUNG BIOLOGICS CO.,LTD.	+3,95 %	40,86 Md
BIOGEN INC.	-21,94 %	29,36 Md
UCB	+53,11 %	24,49 Md
BIOMARIN PHARMACEUTICAL INC.	-5,41 %	17,31 Md
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-44,23 %	11,26 Md
INCYTE CORPORATION	-17,60 %	11,62 Md
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-13,96 %	11,31 Md
SWEDISH ORPHAN BIOVITRUM AB	-0,22 %	8,31 Md